5E Advanced Materials Inc. Q3 FY2026 earnings call

Commercial Milestones

• Signed the company's first long-term off-take heads of agreement for boric acid with a domestic industrial end-user, covering 7,500 tons per year with an option to increase to 10,000 tons per year. The agreement has an initial 5-year term with automatic renewal up to 10 years, fixed pricing with annual escalation.
• The off-take was secured after a March 2026 customer roadshow where the team met with 12 boric acid end-users and distributors across industrial segments, and multiple additional customers have requested commercial proposals, creating a growing pipeline of future off-take agreements.
• The near-term commercial objective is to continue converting customer demand into bankable off-take agreements to support project debt financing, while maintaining discipline on pricing, counterparty quality, and long-term project value.

Product Development Achievements

• Successfully developed stable, free-flowing metaboric acid with approximately 80% B2O3 content, a high-value specialty intermediate product between standard boric acid (56.3% B2O3) and boron oxide (98% B2O3) that can command a higher price point between the two existing product categories.
• Filed a provisional patent application to protect the new metaboric acid intellectual property, and secondary trials are ongoing with samples sent to end-users for testing and qualification to enable future commercial contracts.
• Launched a magnet-grade ferroboron production trial program in February 2026, and initial crucible testing has commenced. First samples are expected to be produced and shared with customers in the coming weeks to support the growing demand for resilient domestic U.S. supply of materials for specialty steel and permanent magnets.

The provided earning call transcript does not disclose detailed financial performance data or revenue contribution breakdowns for any of 5E Advanced Materials' product segments. Only conceptual revenue examples for potential future product sales are provided for illustrative purposes, and no actual current-period financial results for segments are shared.

• Management did not provide formal quantitative financial or operational guidance for future periods in this call. The company outlined clear strategic forward-looking priorities: continue advancing additional off-take agreements with bankable terms to underpin project debt financing in the coming weeks and months, complete active financing diligence, and prepare for the next engineering and construction phase of the Fort Katy project once appropriate conditions are met.
• The commercial team plans to begin marketing 5E's borate product portfolio in Asia in June 2026 to lay the groundwork for future contract proposals, replicating the commercial progress achieved in the U.S. market.
• Management maintains confidence that the operational progress made in Q3 FY2026 has de-risked the Fort Katy project and strengthened the pathway to financing, positioning the company to deliver long-term shareholder value as it advances towards full-scale commercialization.

• The call notes that all forward-looking statements regarding expected future results, production, commercial agreements, project development, and financing are based on current expectations and involve inherent risks and uncertainties that could cause actual results to differ materially and adversely from projected outcomes. Additional detail on risk factors is included in the company's SEC filings, particularly the Form 10-Q for the quarter ended March 31, 2026.
• Finalization of the definitive purchase agreement for the signed off-take heads of agreement is contingent on the completion of project finance diligence, creating execution risk for converting the preliminary agreement into a binding, financeable contract.
• Full advancement to the next engineering phase of the Fort Katy project is conditional on achieving the required commercial and financing conditions, which are not yet fully in place.
• The company relies on successful access to project financing, including government-backed financing facilities, to move forward with full-scale development, which carries inherent approval and funding risk.

No investor or analyst questions were submitted during the Q&A portion of the call. The Q&A session was opened for questions, but no participants joined the question queue, so management concluded the call after closing remarks.